Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Assets (2016 - 2025)

Historic Return on Assets for Cardiff Oncology (CRDF) over the last 14 years, with Q3 2025 value amounting to 0.72%.

  • Cardiff Oncology's Return on Assets fell 600.0% to 0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.51% for FY2024, which is 900.0% down from last year.
  • Per Cardiff Oncology's latest filing, its Return on Assets stood at 0.72% for Q3 2025, which was down 600.0% from 0.64% recorded in Q2 2025.
  • Cardiff Oncology's Return on Assets' 5-year high stood at 0.15% during Q1 2021, with a 5-year trough of 0.72% in Q3 2025.
  • Over the past 5 years, Cardiff Oncology's median Return on Assets value was 0.41% (recorded in 2023), while the average stood at 0.41%.
  • In the last 5 years, Cardiff Oncology's Return on Assets skyrocketed by 12000bps in 2021 and then tumbled by -2100bps in 2024.
  • Quarter analysis of 5 years shows Cardiff Oncology's Return on Assets stood at 0.2% in 2021, then plummeted by -68bps to 0.33% in 2022, then plummeted by -49bps to 0.5% in 2023, then dropped by -14bps to 0.57% in 2024, then decreased by -27bps to 0.72% in 2025.
  • Its Return on Assets stands at 0.72% for Q3 2025, versus 0.64% for Q2 2025 and 0.54% for Q1 2025.